05 April 2023

Safety update of pharmaceuticals products that contains (perindopril/ amlodipine/ rosuvastatin) and pharmaceutical products that contains (amlodipine/ rosuvastatin)

Reference: CIR-2023-00000048

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

 

Safety update of pharmaceuticals products that contains (perindopril/ amlodipine/ rosuvastatin) and pharmaceutical products that contains (amlodipine/ rosuvastatin)

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

==تحذير على المنتجات الطبية .(perindopril- amlodipine- rosuvastatin) الأدوية الحاوية على مجموعة.pdf:

View Document